Idiopathic cytopenia of undetermined significance (ICUS) and idiopathic dysplasia of uncertain significance (IDUS), and their distinction from low risk MDS.
about
Clonal hematopoiesis in acquired aplastic anemiaMyelodysplastic Syndromes Diagnosis: What Is the Role of Molecular Testing?Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromesMDS-associated somatic mutations and clonal hematopoiesis are common in idiopathic cytopenias of undetermined significanceEffects of decitabine on megakaryocyte maturation in patients with myelodysplastic syndromes.Clonal Hematopoiesis of Indeterminate Potential.Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study.Flow Cytometry in the Diagnosis of Myelodysplastic SyndromesIdiopathic cytopenia of undetermined significance and systemic lupus erythematosus.Standardizing the initial evaluation for myelodysplastic syndromes.Importance of classical morphology in the diagnosis of myelodysplastic syndrome.Novel therapeutic strategies in myelodysplastic syndromes: do molecular genetics help?Inhibition of FLT3 in AML: a focus on sorafenib.Unravelling the relevance of CLEC12A as a cancer stem cell marker in myelodysplastic syndrome.Myelodysplastic syndrome versus idiopathic cytopenia of undetermined significance: the role of morphology in distinguishing between these entities.Idiopathic Fatal Pancytopenia: A Case ReportCytopenia levels for aiding establishment of the diagnosis of myelodysplastic syndromesCopper concentrations should be measured under any circumstances.Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditions.Precision therapy for acute myeloid leukemia.RUNX1 Mutations in Inherited and Sporadic Leukemia.Anaemia with inflammation responding to lenalidomide.High activity of sorafenib in FLT3-ITD-positive acute myeloid leukemia synergizes with allo-immune effects to induce sustained responses.
P2860
Q28079733-88D9B98C-DE5F-4877-8822-C49CD8AB1CA2Q28387115-E3675C96-7378-4388-AB3C-A7BB9B6C0051Q28392451-D308715C-7CED-4CFC-837C-812ED772C6BAQ28394317-9F06B6DD-4EC5-45F7-A5BE-7F2D451D47E3Q33431466-64E8A0BC-2E3A-4E41-A4A7-5A1EDE0173B3Q34527941-438E6A2D-39BB-4FDC-9614-7520BE296839Q36107268-2816C995-FF19-477B-B6FE-3728033EE399Q37155338-9EE29D94-1CAD-453C-9E15-5562EB116664Q37320746-2F2FA690-0FDC-4AE3-A2D0-1F2366DDCA85Q38157706-A3BB1513-17A2-4993-92E5-B0F3EA3091CAQ38471249-BC4BBE36-BB2B-4199-B9D4-1DB9D811DAE7Q38716306-587CDE01-88E4-4276-97C3-E980A08A24B8Q38989349-B37B9F0D-00CB-4385-871D-0069C99C9297Q40483682-E0873652-1AF2-45E6-AEF4-6ACA9707901FQ41829928-446A5362-E3D3-4BCC-A47F-7B13E87F4A13Q41951433-77E45DBC-B212-4BAD-B727-78B23CDBC548Q42317637-B5802871-92CA-4708-BEAA-10BDF155F643Q42408379-42EE5395-A150-498E-BC27-1FD166484C51Q47124670-BCAF000C-CAB1-499A-9B2A-816F02ED000AQ49534332-0B8C2026-43EF-4D7A-AED9-0D1B0EDF6D0FQ50074717-2A2716FF-2B83-4EF7-9DD2-AE68BD30C08BQ51396703-57673650-AE23-4527-A2F3-F954F08DDE6DQ54517330-49EE23BB-B002-4E94-99D4-FDB1D68005DC
P2860
Idiopathic cytopenia of undetermined significance (ICUS) and idiopathic dysplasia of uncertain significance (IDUS), and their distinction from low risk MDS.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Idiopathic cytopenia of undete ...... distinction from low risk MDS.
@en
Idiopathic cytopenia of undete ...... distinction from low risk MDS.
@nl
type
label
Idiopathic cytopenia of undete ...... distinction from low risk MDS.
@en
Idiopathic cytopenia of undete ...... distinction from low risk MDS.
@nl
prefLabel
Idiopathic cytopenia of undete ...... distinction from low risk MDS.
@en
Idiopathic cytopenia of undete ...... distinction from low risk MDS.
@nl
P2093
P1433
P1476
Idiopathic cytopenia of undete ...... distinction from low risk MDS.
@en
P2093
Barbara J Bain
Friedrich Wimazal
Ghulam Mufti
Hans-Peter Horny
John M Bennett
Peter Valent
Wolfgang R Sperr
P356
10.1016/J.LEUKRES.2011.09.023
P577
2011-09-13T00:00:00Z